Enorama Pharma AB (publ) (STO:ERMA)
Sweden · Delayed Price · Currency is SEK 1.355
-0.140 (-9.36%)
Feb 10, 2026, 5:29 PM CET
Enorama Pharma AB Market Cap
Enorama Pharma AB has a market cap or net worth of 101.07 million as of February 10, 2026. Its market cap has decreased by -44.66% in one year.
Market Cap
101.07M
Enterprise Value
94.50M
Revenue
3.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.36
Market Cap Chart
Since June 10, 2016, Enorama Pharma AB's market cap has increased from 35.83M to 101.07M, an increase of 182.11%. That is a compound annual growth rate of 11.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 101.07M | -29.06% |
| Dec 30, 2025 | 142.46M | -29.89% |
| Dec 30, 2024 | 203.19M | 77.51% |
| Dec 29, 2023 | 114.47M | 308.04% |
| Dec 30, 2022 | 28.05M | -83.60% |
| Dec 30, 2021 | 171.01M | -12.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.82B |
| Orexo AB | 976.50M |
| Cinclus Pharma Holding AB | 784.63M |
| Dicot Pharma AB | 661.07M |
| Nanexa AB | 592.66M |
| Enzymatica AB | 449.06M |
| Moberg Pharma AB | 430.29M |
| Klaria Pharma Holding AB (publ.) | 243.02M |